4
Changes in Ownership
Kura Oncology, Inc. Filed Acc 0001209191-19-041911
Head of Development & CMO sold 18,000 shares at $21.11 ($379,903)
- Head of Development & CMO acquired 18,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
GUALBERTO ANTONIO · Head of Development & CMO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-07-10 | Exercise or conversion : show line 1 in the form | +18,000 | $6.15 | $110,700 | 357,973 | D |
| 2019-07-10 | Sale : show line 2 in the form | −18,000 | $21.11 | $379,903 | 339,973 | D |
| Open-market sales · 18,000 sh · avg $21.11 · $379,903 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-07-10 | Exercise or conversion : show line 3 in the form Option to purchase common stock | −18,000 | $6.15 | 2027-01-22 | 18,000 | 151,000 | D |
Loading xslF345X03/doc4.xml…